Denver Arthritis Center offers referred infusion care for new patients | Learn More
Living with ANCA vasculitis means dealing with unpredictable inflammation that can affect your kidneys, lungs, sinuses, and other vital organs. You might experience symptoms like persistent fatigue, joint pain, unexplained fever, bloody urine, or difficulty breathing. These signs can appear suddenly and worsen quickly, making prompt diagnosis and treatment essential.
ANCA vasculitis is a serious autoimmune condition where your immune system mistakenly attacks the walls of small blood vessels, causing inflammation that can lead to organ damage if left untreated. The good news is that with proper treatment, many patients achieve remission and can maintain a good quality of life.
Denver Arthritis Clinic specializes in the diagnosis and treatment of ANCA vasculitis and other autoimmune conditions. Our experienced rheumatologists understand the complexities of vasculitis and offer advanced infusion therapies like Rituximab that target the underlying immune dysfunction causing your symptoms. Our dedicated infusion centers in Lowry and Lone Tree provide comfortable, patient-focused environments where you can receive specialized treatment under the care of board-certified physicians and experienced nursing staff.
If you're experiencing symptoms of vasculitis or have been diagnosed with ANCA vasculitis, contact Denver Arthritis Clinic to schedule a consultation. Our ANCA vasculitis specialists will evaluate your condition and develop a personalized treatment plan to help you achieve remission and protect your organ function.
ANCA vasculitis, also called ANCA-associated vasculitis (AAV), is a group of rare autoimmune diseases that cause inflammation of small and medium-sized blood vessels throughout your body. ANCA stands for anti-neutrophil cytoplasmic antibodies, which are abnormal antibodies that attack your own white blood cells, triggering inflammation that damages blood vessel walls. The three main types of ANCA vasculitis are:
The symptoms of ANCA vasculitis vary depending on which organs are affected, but common signs include persistent fatigue and malaise, unexplained fever, unintended weight loss, joint and muscle pain, skin rashes or purple spots, numbness or tingling in your extremities, sinus problems or nosebleeds, coughing up blood, shortness of breath, blood in your urine, and kidney problems. Because these symptoms can mimic other conditions, ANCA vasculitis can be challenging to diagnose. Many patients see multiple doctors before receiving the correct diagnosis.
Diagnosing ANCA vasculitis typically involves blood tests to check for ANCA antibodies (there are two main types: PR3-ANCA and MPO-ANCA), urine tests to look for signs of kidney involvement, imaging studies like chest X-rays or CT scans to evaluate lung and sinus involvement, and sometimes tissue biopsies from affected organs to confirm inflammation. Your rheumatologist will review your complete medical history, perform a thorough physical examination, and order appropriate tests to confirm the diagnosis and determine the extent of organ involvement.
Rituximab (brand names Rituxan and Truxima) has become a cornerstone of treatment for ANCA vasculitis. This medication is a monoclonal antibody that targets and depletes B-cells, a type of white blood cell that plays a key role in producing the ANCA antibodies responsible for blood vessel inflammation. By eliminating these B-cells, Rituximab effectively shuts down the production of harmful antibodies and allows your blood vessels to heal.
Rituximab has been proven highly effective for inducing remission in ANCA vasculitis patients. Clinical studies have shown that it works as well as or better than traditional treatments like cyclophosphamide (an older chemotherapy drug), but with fewer serious side effects. Many patients achieve complete remission with Rituximab, meaning their symptoms resolve and blood tests show no active inflammation. The medication is typically given as a series of infusions over several weeks for initial treatment, followed by maintenance infusions to keep the disease under control and prevent relapses.
At Denver Arthritis Clinic, Rituximab infusions are administered in our comfortable outpatient infusion centers. Each infusion takes several hours, and you'll be monitored closely by our nursing staff throughout the treatment. Before your infusion, you'll receive pre-medications to reduce the risk of infusion reactions. Most patients tolerate Rituximab well, though some experience mild side effects like fatigue, headache, or temporary drops in blood pressure during the infusion.
In addition to Rituximab, high-dose corticosteroids like Solu-Medrol (methylprednisolone) play an important role in treating ANCA vasculitis, especially during the initial treatment phase or during severe flare-ups. Solu-Medrol is a powerful anti-inflammatory medication given through IV infusion that works quickly to suppress the overactive immune response causing blood vessel inflammation. This rapid action is crucial for preventing organ damage when vasculitis is active.
Many patients receive IV Solu-Medrol infusions at the start of their treatment, either alone or in combination with Rituximab. These "pulse" doses of steroids help bring the inflammation under control quickly while the Rituximab begins to take effect. After the initial high-dose treatments, patients typically transition to oral prednisone, which is gradually tapered down over several months as the disease comes under control. The goal is to use the lowest dose of steroids necessary to maintain remission while minimizing the side effects associated with long-term steroid use.
Your treatment plan will be individualized based on the severity of your disease, which organs are affected, and how you respond to therapy. Some patients with severe kidney involvement or life-threatening lung disease may also require a treatment called plasmapheresis (plasma exchange) in addition to medications. Your rheumatologist will work closely with you and any other specialists involved in your care to monitor your response to treatment and adjust your medications as needed.
Early symptoms of ANCA vasculitis can be vague and nonspecific, which often leads to delays in diagnosis. Many patients initially experience general symptoms like persistent fatigue, low-grade fever, unintentional weight loss, and joint pain that might be mistaken for a viral infection or other common conditions.
As the disease progresses, more specific symptoms develop depending on which organs are affected. Sinus and respiratory symptoms like chronic sinus infections, nosebleeds, or coughing are common in granulomatosis with polyangiitis. Kidney involvement might cause blood in the urine that you can't see without a urine test. Lung involvement can lead to shortness of breath or coughing up blood. Skin symptoms might include purple spots or painful nodules.
If you're experiencing persistent unexplained symptoms, especially if you have multiple symptoms occurring together, it's important to see a rheumatologist for evaluation. Early diagnosis and treatment are crucial for preventing permanent organ damage.
ANCA vasculitis specifically refers to vasculitis conditions associated with anti-neutrophil cytoplasmic antibodies (ANCA) in the blood. These antibodies target specific proteins in white blood cells, triggering inflammation in small blood vessels. This is different from large vessel vasculitis like giant cell arteritis or Takayasu arteritis, which affect larger arteries, or medium vessel vasculitis like polyarteritis nodosa.
ANCA vasculitis has characteristic patterns of organ involvement, most commonly affecting the kidneys, lungs, sinuses, and skin. The presence of ANCA antibodies in blood tests helps distinguish this type of vasculitis from other forms.
Yes, many patients with ANCA vasculitis achieve remission with proper treatment. Remission means that your symptoms have resolved, blood tests show no active inflammation, and any organ damage has stabilized. With modern treatments like Rituximab, the majority of patients can achieve remission within several months of starting therapy.
After achieving remission, many patients transition to maintenance therapy with Rituximab infusions given every six months or at other intervals determined by your rheumatologist. The goal of maintenance therapy is to keep your B-cells depleted and prevent the return of ANCA antibodies that could trigger a relapse. Your doctor will also monitor you for potential side effects and adjust your treatment plan as needed based on your response and any changes in your condition.
Rituximab treatment typically begins with an induction phase designed to achieve remission, followed by maintenance therapy to prevent relapses. During the induction phase, you'll receive infusions on a specific schedule over several weeks. Each infusion takes several hours, and you'll receive pre-medications, including antihistamines and sometimes acetaminophen, to reduce the risk of infusion reactions.
At Denver Arthritis Clinic, you'll be comfortably seated in one of our oversized recliners during your infusion. Our nursing staff will monitor your vital signs throughout the treatment and are always available to address any concerns.